SOTERA HEALTH COMPANY Equity Method Investment, Other than Temporary Impairment
SOTERA HEALTH COMPANY (SHC) reported Equity Method Investment, Other than Temporary Impairment of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Income Statement › Other Income
us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment · last filed 2025-02-27
- SOTERA HEALTH COMPANY equity method investment, other than temporary impairment for the quarter ending 2023-12-31 was $0.00.
- SOTERA HEALTH COMPANY equity method investment, other than temporary impairment for the quarter ending 2023-09-30 was $0.00.
- SOTERA HEALTH COMPANY equity method investment, other than temporary impairment for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- SOTERA HEALTH COMPANY equity method investment, other than temporary impairment for the quarter ending 2022-12-31 was $0.00.
- SOTERA HEALTH COMPANY equity method investment, other than temporary impairment for fiscal 2024 was $0.00.
- SOTERA HEALTH COMPANY equity method investment, other than temporary impairment for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- SOTERA HEALTH COMPANY equity method investment, other than temporary impairment for fiscal 2022 was $9.61M.
- SOTERA HEALTH COMPANY equity method investment, other than temporary impairment for fiscal 2021 was $0.00.
| Period end | Equity Method Investment, Other than Temporary Impairment 3 month | Equity Method Investment, Other than Temporary Impairment 6 month | Equity Method Investment, Other than Temporary Impairment 9 month | Equity Method Investment, Other than Temporary Impairment 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-27 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-01 | $0.00 derived: sum of 2 quarters · filed 2023-11-01 | $0.00 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $9.61M derived: sum of 3 quarters · filed 2025-02-27 | $9.61M 10-K · filed 2025-02-27 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-01 | $9.61M derived: sum of 2 quarters · filed 2023-11-01 | $9.61M 10-Q · filed 2023-11-01 | |
| 2022-06-30 | $9.61M 10-Q · filed 2023-08-03 | $9.61M 10-Q · filed 2023-08-03 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | ||
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |